News Conference News ACC 2017 SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients Todd Neale March 17, 2017
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017
News Daily News Timing and Dose Matters When It Comes to Statin Therapy Before CABG Surgery Michael O'Riordan March 16, 2017
News Features The Numbers Game: Door-to-Balloon or First Medical Contact? STEMI Care Still Needs Work Nationwide L.A. McKeown March 16, 2017
News Daily News Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib Todd Neale March 15, 2017
News Daily News Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA Michael O'Riordan March 15, 2017
News Conference News ACC 2017 To Stent or Not to Stent? iFR vs FFR Late Breakers at ACC 2017 Seek to Shake Up Treatment Decisions Caitlin E. Cox March 14, 2017
News Daily News ‘Hub and Spoke’ Model Promises to Improve Access to PCI for STEMI in Low- and Middle-Income Countries L.A. McKeown March 14, 2017
News Daily News NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease Todd Neale March 14, 2017
News Opinion Fellow Talk Career Advice From an Outgoing Advanced Interventional Cardiology Fellow Ankur Kalra March 13, 2017